Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study
International Journal of Dermatology · 11.11.2026
DOI: 10.1111/ijd.70789 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 11.11.2026. Verfasst von Matteo Bianco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
ORCID-Profile: Matteo Bianco, Alessandra Narcisi, Luciano Ibba, Mario Valenti, Sara Di Giulio, Francesco D'Oria, Costanza Falcidia, Giulio Foggi, Antonio Costanzo, Luigi Gargiulo
Zitieren
APA
Bianco, M., Narcisi, A., Ibba, L., Valenti, M., Di Giulio, S., D'Oria, F., Falcidia, C., Foggi, G., Costanzo, A., & Gargiulo, L. (2026). Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study. International Journal of Dermatology. https://doi.org/10.1111/ijd.70789
Vancouver
Bianco M, Narcisi A, Ibba L, Valenti M, Di Giulio S, D'Oria F, et al. Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study. International Journal of Dermatology. 2026. doi:10.1111/ijd.70789
BibTeX
@article{Bianco2026,
author = {Bianco, Matteo and Narcisi, Alessandra and Ibba, Luciano and Valenti, Mario and Di Giulio, Sara and D'Oria, Francesco and Falcidia, Costanza and Foggi, Giulio and Costanzo, Antonio and Gargiulo, Luigi},
title = {Risankizumab in Moderate Plaque Psoriasis: A 156‐Week Retrospective Real‐World Study},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70789}
}
EUVIMED